Justin D. Gover - Sep 9, 2025 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Role
Director
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
Stock symbol
DSGN
Transactions as of
Sep 9, 2025
Transactions value $
$0
Form type
4
Date filed
9/10/2025, 05:18 PM
Previous filing
Jul 30, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gover Justin D. Director C/O DESIGN THERAPEUTICS, INC., 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD /s/ Mustapha Parekh, Attorney-in-Fact 2025-09-10 0001754129

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DSGN Stock option (right to buy) Award $0 +30K $0.00 30K Sep 9, 2025 Common Stock 30K $6.64 Direct F1
transaction DSGN Stock option (right to buy) Award $0 +15.8K $0.00 15.8K Sep 9, 2025 Common Stock 15.8K $6.64 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in equal monthly installments over 36 months following September 9, 2025.
F2 The shares subject to the option will vest in equal monthly installments over 12 months following September 9, 2025.